Medicure Inc. (CVE:MPH – Get Free Report) hit a new 52-week low during trading on Monday . The company traded as low as C$0.92 and last traded at C$0.92, with a volume of 3403 shares. The stock had previously closed at C$1.02.
Medicure Stock Down 9.8 %
The company has a current ratio of 1.87, a quick ratio of 1.29 and a debt-to-equity ratio of 2.06. The company has a market cap of C$9.60 million, a price-to-earnings ratio of -3.68 and a beta of 0.90. The business has a fifty day moving average price of C$1.06 and a two-hundred day moving average price of C$1.08.
Medicure (CVE:MPH – Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The company reported C($0.12) EPS for the quarter. Medicure had a negative net margin of 12.56% and a negative return on equity of 12.90%. The company had revenue of C$5.17 million for the quarter. On average, equities analysts predict that Medicure Inc. will post 0.0756677 earnings per share for the current year.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- How to Use the MarketBeat Excel Dividend Calculator
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Investing In Preferred Stock vs. Common Stock
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- The Role Economic Reports Play in a Successful Investment Strategy
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
